iDtheinvestordatabase
Home / Directory / First Analysis
Likely active: new fund Aug 2023 Verified 5 Nov 2026

First Analysis

Chicago firm that invests in and advises growth focused B2B technology companies, with sector research at the centre of its approach. It has done so for more than 40 years.

Type
VC firm
Location
Chicago, Illinois, United States
Backs
B2B software, Medtech and digital health
Sectors
AI, Healthtech and life sciences, Devtools, Cybersecurity, B2B, HR
Fund size / AUM
$100M First Analysis Fund XIV (Form D offering, 2023); $186.2M gross private fund assets (Form ADV; private funds: 8, of which venture capital: 5)
Latest fund or filing
11 Aug 2023
Portfolio mix
B2B software 65%; Medtech and digital health 16%; Biotech and pharma 13%; Fintech 6% (n=16)

Contacts on file

For First Analysis, the paid file holds: 8 named decision-makers with roles; check size; LinkedIn page.

Get US Complete, $197 Free sample

One-time payment. No subscription. No account.

Notable investments

TPN.healthCycle LabsIntelligent LocationsGradient CyberApplied StemCell

Sources

Last checked 5 Nov 2026. Is something wrong? Tell us.

Appears in 23 lists